S Banerjee1, R Califano2, J Corral3, E de Azambuja4, L De Mattos-Arruda5, V Guarneri6, M Hutka7, K Jordan8, E Martinelli9, G Mountzios10, M A Ozturk11, M Petrova12, S Postel-Vinay13, M Preusser14, C Qvortrup15, M N M Volkov16, J Tabernero5, D Olmos17,18, M H Strijbos19. 1. Gynaecology Unit Royal Marsden Hospital NHS Foundation Trust, Institute of Cancer Research, London. 2. Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK. 3. Department of Medical Oncology, University Hospital Virgen del Rocio, Seville, Spain. 4. Department of Medical Oncology, Institute Jules Bordet, Brussels, Belgium. 5. Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. 6. Medical Oncology 2 and Department of Surgery, Oncology and Gastroenterology, Istituto Oncologico Veneto IRCCS, University of Padova, Padua, Italy. 7. NHS Foundation Trust, University Hospital Southampton, Southampton, UK. 8. Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital of Heidelberg, Heidelberg, Germany. 9. Department of Experimental and Clinical Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy. 10. Department of Medical Oncology, University of Athens School of Medicine Clinical Therapeutics, Athens, Greece. 11. Department of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey. 12. Department of Medical Oncology, Military Medical Academy, Sofia, Bulgaria. 13. Drug Development Unit, (DITEP), Gustave Roussy, Université Paris Saclay, Villejuif, France. 14. Department of Medicine I, Vienna General Hospital (AKH) - Medical University of Vienna, Vienna, Austria. 15. Department of Oncology, Odense University Hospital, Odense, Denmark. 16. Oncology Department, Diagnostic Treatment Centre of International Institute of Biological Systems Dr. Sergey Berezin, St. Petersburg, Russian Federation. 17. Prostate Cancer Clinical Research Unit, CNIO - Spanish National Cancer Research Center, Madrid. 18. Genitourinary Cancer Research Unit, Medical Oncology Department, CNIO-IBIMA Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga, Spain. 19. Department of Medical Oncology, AZ KLINA, Iridium Cancer Network, Brasschaat, Belgium.
Abstract
BACKGROUND: Burnout in health care professionals could have serious negative consequences on quality of patient care, professional satisfaction and personal life. Our aim was to investigate the burnout prevalence, work and lifestyle factors potentially affecting burnout amongst European oncologists ≤40 (YOs). METHODS: A survey was conducted using the validated Maslach Burnout Inventory (MBI) and additional questions exploring work/lifestyle factors. Statistical analyses were carried out to identify factors associated with burnout. RESULTS: Total of 737 surveys (all ages) were collected from 41 European countries. Countries were divided into six regions. Results from 595 (81%) YOs were included (81% medical oncologists; 52% trainees, 62% women). Seventy-one percent of YOs showed evidence of burnout (burnout subdomains: depersonalization 50%; emotional exhaustion 45; low accomplishment 35%). Twenty-two percent requested support for burnout during training and 74% reported no hospital access to support services. Burnout rates were significantly different across Europe (P < 0.0001). Burnout was highest in central European (84%) and lowest in Northern Europe (52%). Depersonalization scores were higher in men compared with women (60% versus 45% P = 0.0001) and low accomplishment was highest in the 26-30 age group (P < 0.01). In multivariable linear regression analyses, European region, work/life balance, access to support services, living alone and inadequate vacation time remained independent burnout factors (P < 0.05). CONCLUSIONS: This is the largest burnout survey in European Young Oncologists. Burnout is common amongst YOs and rates vary across Europe. Achieving a good work/life balance, access to support services and adequate vacation time may reduce burnout levels. Raising awareness, support and interventional research are needed.
BACKGROUND: Burnout in health care professionals could have serious negative consequences on quality of patient care, professional satisfaction and personal life. Our aim was to investigate the burnout prevalence, work and lifestyle factors potentially affecting burnout amongst European oncologists ≤40 (YOs). METHODS: A survey was conducted using the validated Maslach Burnout Inventory (MBI) and additional questions exploring work/lifestyle factors. Statistical analyses were carried out to identify factors associated with burnout. RESULTS: Total of 737 surveys (all ages) were collected from 41 European countries. Countries were divided into six regions. Results from 595 (81%) YOs were included (81% medical oncologists; 52% trainees, 62% women). Seventy-one percent of YOs showed evidence of burnout (burnout subdomains: depersonalization 50%; emotional exhaustion 45; low accomplishment 35%). Twenty-two percent requested support for burnout during training and 74% reported no hospital access to support services. Burnout rates were significantly different across Europe (P < 0.0001). Burnout was highest in central European (84%) and lowest in Northern Europe (52%). Depersonalization scores were higher in men compared with women (60% versus 45% P = 0.0001) and low accomplishment was highest in the 26-30 age group (P < 0.01). In multivariable linear regression analyses, European region, work/life balance, access to support services, living alone and inadequate vacation time remained independent burnout factors (P < 0.05). CONCLUSIONS: This is the largest burnout survey in European Young Oncologists. Burnout is common amongst YOs and rates vary across Europe. Achieving a good work/life balance, access to support services and adequate vacation time may reduce burnout levels. Raising awareness, support and interventional research are needed.
Authors: P Blanchard; D Truchot; L Albiges-Sauvin; S Dewas; Y Pointreau; M Rodrigues; A Xhaard; Y Loriot; P Giraud; J C Soria; G Kantor Journal: Eur J Cancer Date: 2010-06-04 Impact factor: 9.162
Authors: Tait D Shanafelt; Omar Hasan; Lotte N Dyrbye; Christine Sinsky; Daniel Satele; Jeff Sloan; Colin P West Journal: Mayo Clin Proc Date: 2015-12 Impact factor: 7.616
Authors: Tait D Shanafelt; Charles M Balch; Gerald Bechamps; Tom Russell; Lotte Dyrbye; Daniel Satele; Paul Collicott; Paul J Novotny; Jeff Sloan; Julie Freischlag Journal: Ann Surg Date: 2010-06 Impact factor: 12.969
Authors: Tait D Shanafelt; Sonja Boone; Litjen Tan; Lotte N Dyrbye; Wayne Sotile; Daniel Satele; Colin P West; Jeff Sloan; Michael R Oreskovich Journal: Arch Intern Med Date: 2012-10-08
Authors: Tait D Shanafelt; Marilyn Raymond; Michael Kosty; Daniel Satele; Leora Horn; John Pippen; Quyen Chu; Helen Chew; William Benton Clark; Amy E Hanley; Jeff Sloan; William J Gradishar Journal: J Clin Oncol Date: 2014-03-10 Impact factor: 44.544
Authors: Tait D Shanafelt; William J Gradishar; Michael Kosty; Daniel Satele; Helen Chew; Leora Horn; Ben Clark; Amy E Hanley; Quyen Chu; John Pippen; Jeff Sloan; Marilyn Raymond Journal: J Clin Oncol Date: 2014-01-27 Impact factor: 44.544
Authors: Gilberto Morgan; Matteo Lambertini; Hampig Raphael Kourie; Teresa Amaral; Guillem Argiles; Susana Banerjee; Claudia Cardone; Jesus Corral; Letticia De Mattos-Arruda; Akif Öztürk; Mila Petrova; Laurids Poulsen; Michiel Strijbos; Alexandra Tyulyandina; Radu Vidra; Raffaele Califano; Evandro de Azambuja; Pilar Garrido Lopez; Valentina Guarneri; Martin Reck; Vladimir Moiseyenko; Erika Martinelli; Jean-Yves Douillard; Rolf Stahel; Emile Voest; Dirk Arnold; Fatima Cardoso; Paolo Casali; Andrés Cervantes; Alexander M M Eggermont; Alexandru Eniu; Jacek Jassem; George Pentheroudakis; Solange Peters; Keith McGregor; Stefan Rauh; Christoph C Zielinski; Fortunato Ciardiello; Josep Tabernero; Matthias Preusser Journal: ESMO Open Date: 2016-12-07
Authors: Cristian-Virgil Lungulescu; Adina Turcu-Stiolica; Cristina Lungulescu; Elena-Adriana Dumitrescu; Razvan-Aurelian Turcu-Stiolica; Vlad-Mihai Croitoru; Irina-Mihaela Cazacu; Adelina-Silvana Gheorghe; Dana-Lucia Stanculeanu; Daniel Sur Journal: Int J Environ Res Public Health Date: 2022-05-01 Impact factor: 4.614
Authors: Joyce L Neumann; Lih-Wen Mau; Sanya Virani; Ellen M Denzen; Deborah A Boyle; Nancy J Boyle; Jane Dabney; Alexandra De KeselLofthus; Marion Kalbacker; Tippu Khan; Navneet S Majhail; Elizabeth A Murphy; Pamela Paplham; Leslie Parran; Miguel-Angel Perales; Todd H Rockwood; Kim Schmit-Pokorny; Tait D Shanafelt; Elaine Stenstrup; William A Wood; Linda J Burns Journal: Biol Blood Marrow Transplant Date: 2017-12-02 Impact factor: 5.742
Authors: Gilberto Morgan; Matteo Lambertini; Hampig Raphael Kourie; Teresa Amaral; Guillem Argiles; Susana Banerjee; Claudia Cardone; Jesus Corral; Letticia De Mattos-Arruda; Akif Öztürk; Mila Petrova; Laurids Poulsen; Michiel Strijbos; Alexandra Tyulyandina; Radu Vidra; Raffaele Califano; Evandro de Azambuja; Pilar Garrido Lopez; Valentina Guarneri; Martin Reck; Vladimir Moiseyenko; Erika Martinelli; Jean-Yves Douillard; Rolf Stahel; Emile Voest; Dirk Arnold; Fatima Cardoso; Paolo Casali; Andrés Cervantes; Alexander M M Eggermont; Alexandru Eniu; Jacek Jassem; George Pentheroudakis; Solange Peters; Keith McGregor; Stefan Rauh; Christoph C Zielinski; Fortunato Ciardiello; Josep Tabernero; Matthias Preusser Journal: ESMO Open Date: 2016-12-07
Authors: Maria Vittoria Dieci; Francesco Massari; Raffaele Giusti; Alessandro Inno; Giuseppe Lombardi; Laura Noto; Antonio Passaro; Filippo Pietrantonio; Francesca Spada; Monica Valente; Massimo Di Maio; Valter Torri Journal: ESMO Open Date: 2018-10-21
Authors: K H J Lim; K Murali; K Kamposioras; K Punie; C Oing; M O'Connor; E Thorne; T Amaral; P Garrido; M Lambertini; B Devnani; C B Westphalen; G Morgan; J B A G Haanen; C Hardy; S Banerjee Journal: ESMO Open Date: 2021-06-30